Clinical Trials
🇪🇺 EMA Page 7EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 73–84 of 139 articles
EULAR 2026: Immutep's IMP761 Phase I Data Preview
Purdue Pharma Dissolution Approved: What It Means for Opioid Crisis
CAR-T Cell Therapy Europe: Clinical Trials, Safety & Market Access Insights
Cerus Corporation INTERCEPT Blood System Advances Through European Regulatory Review and Phase 3 Trials
EU Biopharma Clinical Trials: AI & Gene Therapy Surge
BioPharma Clinical Trials EU: Daily Insights
PureTech Reports Positive LYT-200 Clinical Results for Myeloid Malignancies in 2025 Annual Results
EnteroBiotix Raises £19M to Launch Phase 2b Microbiome Trial for Irritable Bowel Syndrome Treatment
Novel Immunotherapies Advanced Melanoma: EMA Approval & Phase 3 Insights
EU Clinical Trial Ethics Committees: Analysis of Decision Patterns & Timelines
EU Clinical Trial Site Selection: Impact of New Qualification Requirements on Timelines
Boehringer Ingelheim's Survodutide Achieves 16.6% Weight Loss in Phase 2 Obesity Trial, Outperforming Current Market Leaders